The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Abstract
FK506 and rapamycin are related immunosuppressive compounds that block helper T cell activation by interfering with signal transduction. In vitro, both drugs bind and inhibit the FK506-binding protein (FKBP) proline rotamase. Saccharomyces cerevisiae cells treated with rapamycin irreversibly arrested in the G1 phase of the cell cycle. An FKBP-rapamycin complex is concluded to be the toxic agent because (i) strains that lack FKBP proline rotamase, encoded by FPR1 , were viable and fully resistant to rapamycin and (ii) FK506 antagonized rapamycin toxicity in vivo. Mutations that conferred rapamycin resistance altered conserved residues in FKBP that are critical for drug binding. Two genes other than FPR1 , named TOR1 and TOR2 , that participate in rapamycin toxicity were identified. Nonallelic noncomplementation between FPR1 , TOR1 , and TOR2 alleles suggests that the products of these genes may interact as subunits of a protein complex. Such a complex may mediate nuclear entry of signals required for progression through the cell cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffman, C. S., & Winston, F. (1987) · Gene · doi:10.1016/0378-1119(87)90131-4 · Cited by 2,479
Cyclophilin: A Specific Cytosolic Binding Protein for Cyclosporin A
Handschumacher, R. E., Harding, M. W., Rice, J., Drugge, R. J., & Speicher, D. W. (1984) · Science · doi:10.1126/science.6238408 · Cited by 1,673
Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands
Schreiber, S. L. (1991) · Science · doi:10.1126/science.1702904 · Cited by 1,494
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins
Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T., & Schmid, F. X. (1989) · Nature · doi:10.1038/337476a0 · Cited by 1,407
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
Harding, M. W., Galat, A., Uehling, D. E., & Schreiber, S. L. (1989) · Nature · doi:10.1038/341758a0 · Cited by 1,396
Laboratory course manual for methods in yeast genetics
Sherman, F., Fink, G. R., & Hicks, J. B. (1986) · Cold Spring Harbor Laboratory eBooks · Cited by 1,231
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin
Takahashi, N., Hayano, T., & Suzuki, M. (1989) · Nature · doi:10.1038/337473a0 · Cited by 1,078
Contingent Genetic Regulatory Events in T Lymphocyte Activation
Crabtree, G. R. (1989) · Science · doi:10.1126/science.2783497 · Cited by 1,072
Siekierka, J. J., Hung, S. H. Y., Poe, M., Lin, C. S., & Sigal, N. H. (1989) · Nature · doi:10.1038/341755a0 · Cited by 1,010
Bierer, B. E., Mattila, P. S., Standaert, R. F., Herzenberg, L. A., Burakoff, S. J., Crabtree, G., & Schreiber, S. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9231 · Cited by 696
Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T Cell Activation
Emmel, E. A., Verweij, C. L., Durand, D. B., Higgins, K. M., Lacy, E., & Crabtree, G. R. (1989) · Science · doi:10.1126/science.2595372 · Cited by 664
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
Tocci, M. J., Matkovich, D. A., Collier, K. A., Kwok, P., Dumont, F., Lin, S., Degudicibus, S., Siekierka, J. J., Chin, J., & Hutchinson, N. I. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.2.718 · Cited by 662
Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.
Krönke, M., Leonard, W. J., Depper, J. M., Arya, S. K., Wong-Staal, F., Gallo, R. C., Waldmann, T. A., & Greene, W. C. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.16.5214 · Cited by 605
Dumont, F. J., Staruch, M. J., Koprak, S. L., Melino, M. R., & Sigal, N. H. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.1.251 · Cited by 603
Fischer, G., & Schmid, F. X. (1990) · Biochemistry · doi:10.1021/bi00461a001 · Cited by 369
Dumont, F. J., Melino, M. R., Staruch, M. J., Koprak, S. L., Fischer, P. A., & Sigal, N. H. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.4.1418 · Cited by 355
Probing Immunosuppressant Action with a Nonnatural Immunophilin Ligand
Bierer, B. E., Somers, P. K., Wandless, T. J., Burakoff, S. J., & Schreiber, S. L. (1990) · Science · doi:10.1126/science.1700475 · Cited by 352
The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes.
Mattila, P. S., Ullman, K. S., Fiering, S., Emmel, E. A., McCutcheon, M., Crabtree, G. R., & Herzenberg, L. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07893.x · Cited by 349
Steinmann, B., Bruckner, P., & Superti-Furga, A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35315-2 · Cited by 318
Molecular cloning and overexpression of the human FK506-binding protein FKBP
Standaert, R. F., Galat, A., Verdine, G. L., & Schreiber, S. L. (1990) · Nature · doi:10.1038/346671a0 · Cited by 312
Solution Structure of FKBP, a Rotamase Enzyme and Receptor for FK506 and Rapamycin
Michnick, S. W., Rosen, M. K., Wandless, T. J., Karplus, M., & Schreiber, S. L. (1991) · Science · doi:10.1126/science.1709301 · Cited by 301
Heitman, J., Movva, N. R., Hiestand, P. C., & Hall, M. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1948 · Cited by 294
Self-citationCianciotto, N. P., Eisenstein, B. I., Mody, C. H., Toews, G. B., & Engleberg, N. C. (1989) · Infection and Immunity · doi:10.1128/iai.57.4.1255-1262.1989 · Cited by 227
DNA sequence of mip, a Legionella pneumophila gene associated with macrophage infectivity
Engleberg, N. C., Carter, C., Weber, D. R., Cianciotto, N. P., & Eisenstein, B. I. (1989) · Infection and Immunity · doi:10.1128/iai.57.4.1263-1270.1989 · Cited by 206
Inhibition of FKBP Rotamase Activity by Immunosuppressant FK506: Twisted Amide Surrogate
Rosen, M., Standaert, R., Galat, A., Nakatsuka, M., & Schreiber, S. (1990) · Science · doi:10.1126/science.1693013 · Cited by 200
Stearns, T., & Botstein, D. (1988) · Genetics · doi:10.1093/genetics/119.2.249 · Cited by 186
Catalysis of protein folding by cyclophilins from different species
Schönbrunner, E. R., Mayer, S., Tropschug, M., Fischer, G., Takahashi, N., & Schmid, F. X. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67841-5 · Cited by 181
Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation.
BAKER, H., SIDOROWICZ, A., SEHGAL, S. N., & VÉZINA, C. (1978) · The Journal of Antibiotics · doi:10.7164/antibiotics.31.539 · Cited by 166
Isolation and sequence of an FK506-binding protein from N. crassa which catalyses protein folding
Tropschug, M., Wächter, E., Mayer, S., Schönbrunner, E. R., & Schmid, F. X. (1990) · Nature · doi:10.1038/346674a0 · Cited by 153
Suppression of B cell activation by cyclosporin A, FK506 and rapamycin
Wicker, L. S., Boltz, R. C., Matt, V., Nichols, E. A., Peterson, L. B., & SIGAL, N. H. (1990) · European Journal of Immunology · doi:10.1002/eji.1830201017 · Cited by 150
Solution structure of the major binding protein for the immunosuppressant FK506
Moore, J. M., Peattie, D. A., Fitzgibbon, M. J., & Thomson, J. A. (1991) · Nature · doi:10.1038/351248a0 · Cited by 146
Rapamycin and FK506 binding proteins (immunophilins)
Fretz, H., Albers, M. W., Gałat, A., Standaert, R. F., Lane, W. S., Burakoff, S. J., Bierer, B. E., & Schreiber, S. L. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00004a051 · Cited by 134
Granelli‐Piperno, A., Nolan, P., Inaba, K., & Steinman, R. M. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.6.1869 · Cited by 130
Maki, N., Sekiguchi, F., Nishimaki, J., Miwa, K., Hayano, T., Takahashi, N., & Suzuki, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5440 · Cited by 119
Wiederrecht, G., Brizuela, L., Elliston, K. O., SIGAL, N. H., & Siekierka, J. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.1029 · Cited by 98
Brabletz, T., Pietrowski, I., & Serfling, E. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.1.61 · Cited by 94
Kusch, M., & Edgar, R. S. (1986) · Genetics · doi:10.1093/genetics/113.3.621 · Cited by 88
Homyk, T., & Emerson, C. P. (1988) · Genetics · doi:10.1093/genetics/119.1.105 · Cited by 81
Hays, T. S., Deuring, R., Robertson, B., Prout, M., & Fuller, M. T. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.875 · Cited by 70
Atkinson, K. D. (1985) · Genetics · doi:10.1093/genetics/111.1.1 · Cited by 31
Foxwell, B. M. J., HIESTAND, P. C., Wenger, R. M., & Ryffel, B. (1988) · Transplantation · doi:10.1097/00007890-198808001-00007 · Cited by 22
Cited by
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Self-citationCalcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
The PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749
Metadata
- Authors
- Heitman, J., Movva, N. R., & Hall, M. N.
- Venue
- Science
- Published
- 1991-08-23
- Volume
- 253
- Issue
- 5022
- Pages
- 905-909
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2063013559
- Cited by
- 2,006
- References
- 41
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.